Shekel is too strong, says Ronald McDonald

Big Mac in Israel is 6.9% more expensive than US price, meaning that – in the flurry-filled world of Big Mac economics – the Shekel is about 6.9% too strong.

July 29, 2014 12:58
2 minute read.
A McDonald's restaurant in Israel.

A McDonald's restaurant in Israel.. (photo credit: REUTERS/Ronen Zvulun)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

While the Israel Manufacturer’s Association and a coalition of exporters have long complained that Israel’s currency is too strong, they got an unlikely endorsement on Friday from McDonald’s.

More specifically, The Economist released its latest Big Mac Index, a simple, lighthearted and popular indicator of whether currencies are valued correctly.

Be the first to know - Join our Facebook page.

The idea, according to the newspaper, is this: The price of a Big Mac captures a lot of what’s going on in a given economy, from labor to rent to the price of produce. Since Big Macs are just about the same in most countries, they should, according to the economic theory of purchasing power parity, cost about the same when converted into the same currency.

“Since a Big Mac costs 48 kroner ($7.76) in Norway and only $4.80 in America, the kroner is overvalued by 62 percent according to this lighthearted, protein-rich analysis, making it the most puffed-up currency in the index,” The Economist offered by way of example.

In Israel, the cost of a Big Mac in 2014 is NIS 17.50, which at the NIS 3.41 exchange rate comes out to $5.13.

That figure is 6.9% more expensive than the US Big Mac price of $4.80, meaning that – in the flurry-filled world of the Big Mac economics, at least – the Shekel is about 6.9% too strong.

If Ronald McDonald were the world’s central banker, the shekel would be 3.65 to the dollar (and Israel’s exporters would be thrilled, as their products would suddenly seem much cheaper to customers around the globe).

The Big Mac Index, of course, is just a rough approximation, and not a substitute for a thorough economic analysis.

In testimony to the Knesset Finance Committee earlier in July, Bank of Israel Governor Karnit Flug said: “What is behind the appreciation in Israel? Israel’s economy is in a relatively good situation.”

“We have a continuing current account surplus, and net foreign direct investment by nonresident investors who see Israeli companies as attractive for investment,” Flug said.

In the first half of 2014, the shekel strengthened by about 1.6% against the dollar, but the Bank of Israel’s policy is aimed more toward easing the trend of appreciation than reversing or distorting it.

Even by Big Mac standards, a 6.9% deviation isn’t much. The Economist also has a more “gourmet” version of the Big Mac Index, however, which takes into account the fact that in poorer countries, labor costs are lower.

When it controls for the size of Israel’s economy, it finds that the shekel is overvalued by 26.8%.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection